In the present study, we investigated the effects of TLR2 pharmacological blockade by an inhibiting antibody as well as genetic TLR2 deficiency on survival and neurofunctional outcome after cardiac arrest (CA) and cardiopulmonary resuscitation (CPR) in mice. This evidence concerns the gene TLR2 and cardiac arrest.